Comparison of 2 Fasciotomes for Treatment of Patients With Chronic Exertional Compartment Syndrome of the Anterior Leg.

Autor:	de Bruijn JA; Department of Surgery, Máxima Medical Center, Veldhoven, the Netherlands., van Zantvoort APM; Department of Surgery, Máxima Medical Center, Veldhoven, the Netherlands., Hundscheid HPH; Department of Surgery, Máxima Medical Center, Veldhoven, the Netherlands., Hoogeveen AR; Department of Sports Medicine, Máxima Medical Center, Veldhoven, the Netherlands., van Eerten P; Department of Surgery, Máxima Medical Center, Veldhoven, the Netherlands., Teijink JAW; Department of Surgery, Catherina Hospital, Eindhoven, the Netherlands.; Department of Epidemiology, CAPHRI Research School, Maastricht University, Maastricht, the Netherlands., Scheltinga MR; Department of Surgery, Máxima Medical Center, Veldhoven, the Netherlands.
Jazyk:	angličtina
Zdroj:	Orthopaedic journal of sports medicine [Orthop J Sports Med] 2021 Nov 29; Vol. 9 (11), pp. 23259671211051358. Date of Electronic Publication: 2021 Nov 29 (Print Publication: 2021).
DOI:	10.1177/23259671211051358
Abstrakt:	Background: Chronic exertional compartment syndrome (CECS) of the anterior leg compartment (ant-CECS) is frequently treated with a minimally invasive fasciotomy. Several operative techniques and operative devices exist, but none have been compared in a systematic and randomized manner. Purpose: To compare efficacy, safety, and postoperative pain of a novel operative device (FascioMax fasciotome) with a widely accepted device created by Due and Nordstrand (Due fasciotome) during a minimally invasive fasciotomy for ant-CECS. Study Design: Randomized controlled trial; Level of evidence, 2. Methods: Patients with bilateral isolated ant-CECS between October 2013 and April 2018 underwent a minimally invasive fasciotomy using the FascioMax fasciotome in 1 leg and the Due fasciotome in the contralateral leg in a single operative session. Symptom reduction at 3 to 6 months and >1 year, postoperative pain within the first 2 weeks, peri- and postoperative complications, and ability to regain sports were assessed using diaries, physical examination, and timed questionnaires. Results: Included in the study were 50 patients (66% female; median age, 22 years [range, 18-65 years]). No differences between the devices were found in terms of perioperative complications (both had none), minor postoperative complications including hematoma and superficial wound infection (overall complication rate: FascioMax, 8% vs Due, 6%), or reduction of CECS-associated symptoms at rest and during exercise. At long-term follow-up (>1 year), 82% of the patients were able to regain their desired type of sport, and 67% (33/49) were able to exercise at a level that was comparable with or higher than before their CECS-associated symptoms started. Conclusion: Both the FascioMax and the Due performed similarly in terms of efficacy, safety, and levels of pain within the first 2 weeks postoperatively. Registration: NL4274; Netherlands Trial Register. Competing Interests: The authors declared that there are no conflicts of interest in the authorship and publication of this contribution. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto. (© The Author(s) 2021.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu